Analytical Data
-
Gene name
C11orf73
- Application
-
Alternative Names
C11orf73; Chromosome 11 open reading frame 73; CK073_HUMAN; FLJ43020; Hikeshi; HSPC138; HSPC179; L7RN6; Lethal Chr 7 Rinchik 6; OPI10; Protein Hikeshi; Uncharacterized protein C11orf73
-
Species
Human
-
Source
E. coli
-
Tag
N- His-SUMO
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q53FT3
-
Expression Region
1-197aa
-
Molecular Weight
37.6 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C11orf73, also known as the hypothetical protein C11orf73, has emerged as a significant subject of research due to its potential implications in various biological processes and diseases. Discovered through genomic studies, C11orf73 is located on chromosome 11 and is associated with several cellular functions, including cell cycle regulation, apoptosis, and possibly immune responses. Despite its identification, the specific functions and mechanisms of C11orf73 remain largely uncharacterized, prompting researchers to investigate its role in human health and disease. Recent studies have suggested that alterations in the expression of C11orf73 may be linked to certain malignancies and neurodegenerative disorders, highlighting its potential as a biomarker or therapeutic target. As recombinant protein technology advances, producing C11orf73 in a laboratory setting allows for in-depth functional analyses, paving the way for understanding its biological significance. Researchers are actively exploring its interactions with other proteins and cellular pathways, seeking to unravel its contribution to pathological states. This ongoing research into C11orf73 aims to elucidate its role in human physiology and disease, potentially offering new insights for targeted therapeutic strategies.
